(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
1.
|
|
NAME OF REPORTING PERSONS
2019B Cayman Limited
|
2.
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
|
(A)
|
x
|
|
|
(B)
|
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
AF
|
5.
|
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e) ¨
|
6.
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7.
|
SOLE VOTING POWER
2,743,868 Ordinary Shares (See Item 5)
|
8.
|
SHARED VOTING POWER
0
|
9.
|
SOLE DISPOSITIVE POWER
2,743,868 Ordinary Shares (See Item 5)
|
10.
|
SHARED DISPOSITIVE POWER
0
|
11.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,743,868 Ordinary Shares (See Item 5)
|
12.
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
13.
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.1%*
|
14.
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
|
|
|
|
|
|
*
|
Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as
reported in the annual report on Form 20-F (the “Form 20-F”) filed with the Securities Exchange Commission (the
“SEC”) by the Issuer (as defined below) on March 12, 2020.
|
1.
|
|
NAME OF REPORTING PERSONS
CITIC CAPITAL CHINA PARTNERS IV, L.P.
|
2.
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
|
(A)
|
x
|
|
|
(B)
|
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
OO
|
5.
|
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e) ¨
|
6.
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7.
|
SOLE VOTING POWER
3,743,868 Ordinary Shares (See Item 5)
|
8.
|
SHARED VOTING POWER
0
|
9.
|
SOLE DISPOSITIVE POWER
3,743,868 Ordinary Shares (See Item 5)
|
10.
|
SHARED DISPOSITIVE POWER
0
|
11.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,743,868 Ordinary Shares (See Item 5)
|
12.
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
13.
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.7%*
|
14.
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
|
|
|
|
|
|
*
|
Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as
reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020.
|
1.
|
|
NAME OF REPORTING PERSONS
CCP IV GP LTD.
|
2.
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
|
(A)
|
x
|
|
|
(B)
|
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
AF
|
5.
|
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e) ¨
|
6.
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7.
|
SOLE VOTING POWER
3,743,868 Ordinary Shares (See Item 5)
|
8.
|
SHARED VOTING POWER
0
|
9.
|
SOLE DISPOSITIVE POWER
3,743,868 Ordinary Shares (See Item 5)
|
10.
|
SHARED DISPOSITIVE POWER
0
|
11.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,743,868 Ordinary Shares (See Item 5)
|
12.
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
13.
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.7%*
|
14.
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
|
|
|
|
|
|
*
|
Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as
reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020.
|
1.
|
|
NAME OF REPORTING PERSONS
CITIC CAPITAL PARTNERS LIMITED
|
2.
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
|
(A)
|
x
|
|
|
(B)
|
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
AF
|
5.
|
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e) ¨
|
6.
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7.
|
SOLE VOTING POWER
3,743,868 Ordinary Shares (See Item 5)
|
8.
|
SHARED VOTING POWER
0
|
9.
|
SOLE DISPOSITIVE POWER
3,743,868 Ordinary Shares (See Item 5)
|
10.
|
SHARED DISPOSITIVE POWER
0
|
11.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,743,868 Ordinary Shares (See Item 5)
|
12.
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
13.
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.7%*
|
14.
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
|
|
|
|
|
|
*
|
Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as
reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020.
|
1.
|
|
NAME OF REPORTING PERSONS
CITIC CAPITAL HOLDINGS LIMITED
|
2.
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
|
(A)
|
x
|
|
|
(B)
|
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
AF
|
5.
|
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e) ¨
|
6.
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
HONG KONG
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7.
|
SOLE VOTING POWER
3,743,868 Ordinary Shares (See Item 5)
|
8.
|
SHARED VOTING POWER
0
|
9.
|
SOLE DISPOSITIVE POWER
3,743,868 Ordinary Shares (See Item 5)
|
10.
|
SHARED DISPOSITIVE POWER
0
|
11.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,743,868 Ordinary Shares (See Item 5)
|
12.
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
|
13.
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.7%*
|
14.
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
|
|
|
|
|
|
*
|
Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as
reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020.
|
This Amendment No. 6 to Schedule 13D
(this “Amendment No. 6”) filed by 2019B Cayman, CCCP IV, CCP IV GP, CCPL and CCHL (collectively, the
“Reporting Persons”) amends and supplements the Schedule 13D previously filed jointly with the SEC on June
18, 2018 (the “Initial Filing”) by CCRE Holdings Limited, CCMB and CCHL, as amended by Amendment No. 1 to
the Initial Filing filed on August 27, 2018 by CCRE Holdings Limited, CCMB and CCHL (the “Amendment No.
1”), Amendment No. 2 to the Initial Filing filed on October 16, 2018 by CCCP IV, CCP IV GP, CCPL, CCHL and CCMB
(the “Amendment No. 2”), Amendment No. 3 to the Initial Filing filed on October 31, 2018 (the
“Amendment No. 3”) by CCCP IV, CCP IV GP, CCPL and CCHL, Amendment No. 4 to the Initial Filing filed on
September 20, 2019 (the “Amendment No. 4”) by CCCP IV, CCP IV GP, CCPL and CCHL and Amendment No. 5 to the
Initial Filing filed on January 24, 2020 by CCCP IV, CCP IV GP, CCPL and CCHL (the “Amendment No. 5,”
together with the Initial Filing, Amendment No. 1, Amendment No. 2, Amendment No. 3 and Amendment No. 4, the
“Original Schedule 13D”), with respect to the ordinary shares, par value $0.0001 per share (the
“Ordinary Shares”), of China Biologic Products Holdings, Inc., a company organized under the laws of the
Cayman Islands (the “Issuer”). The Reporting Persons entered into a joint filing agreement, dated as of
April 8, 2020, a copy of which is filed with this Amendment No. 6 as Exhibit 1.
Except as specifically provided herein,
this Amendment No. 6 does not modify any of the information previously reported in the Original Schedule 13D. Capitalized
terms used but not defined in this Amendment No. 6 have the respective meanings set forth in the Original Schedule 13D.
Item 2.
|
Identity and Background
|
Item 2 is amended by replacing the Schedule
A to the Original Schedule 13D with the Schedule A hereto and supplemented by adding the following:
2019B Cayman is an exempted company incorporated
with limited liability under the laws of the Cayman Islands. Its principal business address is 28/F, CITIC Tower, 1 Tim Mei Avenue,
Central, Hong Kong. Its principal business is investment holdings.
During the last five years, none of the
Reporting Persons and, to the best of their knowledge, any of the persons listed on Schedule A hereto has been: (i) convicted in
a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws
or finding any violation with respect to such laws.
Item 3.
|
Source and Amount of Funds or Other Consideration
|
Item 3 of the Original Schedule 13D is hereby
amended and supplemented by adding the following at the end thereof:
On March 30, 2020, CCCP IV transferred 2,477,335
Ordinary Shares to its wholly-owned subsidiary, 2019B Cayman, for an aggregate purchase price of US$214 million. The source of
fund is funding from an affiliate.
Item 5.
|
Interest in Securities
of the Issuer
|
Item 5 of the Original Schedule 13D is hereby
amended and restated in its entirety to read as follows:
(a), (b) The following table sets forth
the beneficial ownership of Ordinary Shares of the Issuer by each of the Reporting Persons as of the date hereof.
|
|
|
|
|
|
|
|
Number of Ordinary Shares Beneficially Owned by Each Reporting Person with:
|
Reporting Person
|
|
Amount beneficially
owned(1)
|
|
|
Percent of class(2)
|
|
|
Sole power
to vote or direct the vote
|
|
|
Shared power to vote or to direct the vote
|
|
Sole power to dispose or to direct the disposition of
|
|
|
Shared power to dispose or to direct the
disposition of
|
|
|
(in Ordinary Shares)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019B Cayman
|
|
|
2,743,868(3)
|
|
|
|
7.1%
|
|
|
|
2,743,868
|
|
|
0
|
|
|
2,743,868
|
|
|
0
|
CCCP IV
|
|
|
3,743,868(4)
|
|
|
|
9.7%
|
|
|
|
3,743,868
|
|
|
0
|
|
|
3,743,868
|
|
|
0
|
CCP IV GP
|
|
|
3,743,868(5)
|
|
|
|
9.7%
|
|
|
|
3,743,868
|
|
|
0
|
|
|
3,743,868
|
|
|
0
|
CCPL
|
|
|
3,743,868(5)
|
|
|
|
9.7%
|
|
|
|
3,743,868
|
|
|
0
|
|
|
3,743,868
|
|
|
0
|
CCHL
|
|
|
3,743,868(5)
|
|
|
|
9.7%
|
|
|
|
3,743,868
|
|
|
0
|
|
|
3,743,868
|
|
|
0
|
|
(1)
|
Beneficial ownership is determined in accordance with Rule 13d-3 of the General Rules and Regulations under the Act, as amended.
|
|
(2)
|
Percentage is calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020
as reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020.
|
|
(3)
|
Includes 266,533 Ordinary Shares to be acquired from Double Double pursuant to the January 2020 SPA.
|
|
(4)
|
Includes 2,743,868 Ordinary Shares beneficially owned by 2019B Cayman.
|
|
(5)
|
Represents 3,743,868 Ordinary Shares beneficially owned by CCCP IV.
|
CCCP IV is the parent company of 2019B Cayman
and may be deemed to have beneficial ownership of the securities held of record and deemed to be beneficially owned by 2019B Cayman.
Each of CCPL and CCHL may be deemed to beneficially
own the Ordinary Shares beneficially owned by CCCP IV, however each such Reporting Person hereby expressly disclaims such beneficial
ownership except to the extent of its pecuniary interest therein.
Because of the arrangements in the Consortium
Agreement, the parties to that agreement are deemed to have formed a “group” for purposes of Section 13(d)(3) of the
Act, and such “group” is deemed to beneficially own an aggregate of 26,374,631 Ordinary Shares, which represents approximately
68.5% of the total number of Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the Form 20-F filed with
the SEC by the Issuer on March 12, 2020. Neither the filing of this Amendment No. 6 nor any of its contents, however, shall be
deemed to constitute an admission by the Reporting Persons that any of them is the beneficial owner of any of the Ordinary Shares
beneficially owned in the aggregate by other members of the Buyer Consortium and their respective affiliates for purposes of Section
13(d) of the Act or for any other purpose, and such beneficial ownership is expressly disclaimed.
(c) To
the best of the Reporting Persons’ knowledge, except as set forth herein, there have been no transactions effected with respect
to any Ordinary Shares during the past 60 days by any of the persons named in response to Item 5(a)-(b).
(d) To
the best knowledge of the Reporting Persons, except as set forth herein, no person (other than the Reporting Persons) is known
to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from
the sale of, any securities covered by this Amendment No. 6.
(e) Not
applicable.
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
Item 6 of the Original Schedule 13D is hereby
amended and supplemented by adding the following before the last paragraph thereof:
The source of funds of 2019B Cayman for
the transactions contemplated under its January 2020 SPA will be primarily from revolving credit facilities of CCCP IV provided
by a third-party financial institution. CCCP IV obtained the revolving credit facilities from a third-party commercial bank for
general working capital purposes and to facilitate investments made by CCCP IV in accordance with the terms of its partnership
agreement.
On January 16, 2020, CCCP IV, as borrower,
and CCP IV GP, as general partner, entered into a revolving facilities agreement (the “Revolving Facilities Agreement”)
with SOCIÉTÉ GÉNÉRALE, as original lender. The Revolving Facilities Agreement provides for a US$170,000,000
committed revolving credit facility (“Facility A”) and a US$180,000,000 uncommitted revolving credit facility
(“Facility B”, and together with Facility A, the “Revolving Facilities”), with a maturity
date of January 15, 2021, which, upon CCCP IV’s request and subject to certain conditions, may be extended to January 15,
2022. Borrowings under the Revolving Facilities are subject to customary conditions. The Facilities are secured by undrawn capital
commitments of the limited partners of CCCP IV (including the right to call for such capital commitments) and a deposit account
for the purposes of receiving capital contributions from the limited partners of CCCP IV, among other things.
Borrowings under each of the Revolving Facilities
will bear interest at a rate per annum equal to the sum of (i) LIBOR for the relevant interest period, which may be, as selected
by the borrower, one (1) week, two (2) weeks, one (1) month, two (2) months, three (3) months or six (6) months or any other period
agreed to by the parties, and (ii) an applicable margin. All payments of principal and interest with respect to the Revolving Facilities
will be due and payable as specified in the Revolving Facilities Agreement. CCCP IV intends to repay the borrowings under the Revolving
Facilities with capital under the management of its affiliate. The Revolving Facilities Agreement contains representations and
warranties, affirmative and negative covenants, including financial maintenance covenants, and events of default, that CCCP IV
believes are usual and customary for such credit facilities.
The foregoing summary of the Revolving Facilities
Agreement does not purport to be complete and is qualified in its entirety by reference to the Revolving Credit Agreement itself,
a copy of which is attached hereto as Exhibit 5 and incorporated herein by reference in its entirety.
Item 7.
|
Materials to be Filed as Exhibits.
|
Item 7 of the Original Schedule 13D is hereby
amended and supplemented by adding the following after the last paragraph thereof:
|
†
|
Portions of this Exhibit have been redacted because confidential treatment for those terms has been requested. The redacted
materials have been separately provided to the SEC, and the redacted portions have been marked at the appropriate places with three
asterisks inside of brackets “[***]”.
|
SIGNATURES
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: April 8, 2020
|
2019B CAYMAN LIMITED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Rikizo Matsukawa
|
|
|
|
|
Name:
|
|
Rikizo Matsukawa
|
|
|
|
|
Title:
|
|
Director
|
|
|
|
|
|
|
|
|
|
CITIC Capital China Partners IV, L.P.
|
|
|
|
|
|
By: CCP IV GP LTD., its General Partner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Chan Kai Kong
|
|
|
|
|
Name:
|
|
Chan Kai Kong
|
|
|
|
|
Title:
|
|
Director
|
|
|
|
|
|
|
|
|
|
CCP IV GP LTD.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Chan Kai Kong
|
|
|
|
|
Name:
|
|
Chan Kai Kong
|
|
|
|
|
Title:
|
|
Director
|
|
|
|
|
|
|
|
|
|
CITIC CAPITAL PARTNERS LIMITED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Chan Kai Kong
|
|
|
|
|
Name:
|
|
Chan Kai Kong
|
|
|
|
|
Title:
|
|
Director
|
|
|
|
|
|
|
|
|
|
CITIC CAPITAL HOLDINGS LIMITED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Yichen Zhang
|
|
|
|
|
Name:
|
|
Yichen Zhang
|
|
|
|
|
Title:
|
|
Director
|
|
|
|
|
|
|
|
|
[Signature page to the Amendment No.
6 to Schedule 13D]
SCHEDULE A
DIRECTORS AND EXECUTIVE OFFICERS OF THE
REPORTING PERSONS
Name
|
|
Citizenship
|
|
Present Principal Occupation or Employment
|
|
Business Address
|
|
|
|
|
|
|
|
Zhang, Yichen
|
|
Hong Kong
|
|
Chairman, Chief Executive Officer and Director – CCHL;
Director – CITIC Capital Partners Limited
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Matsukawa, Rikizo
|
|
Japan
|
|
Managing Director – CCHL; Director – CCP IV GP Ltd. and 2019B Cayman Limited
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Chew, Boon Lian
|
|
Singapore
|
|
Senior Managing Director – CCHL; Managing Partner – CITIC Capital Partners Limited
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Fung Yee Man, Annie
|
|
Britain
|
|
Chief Operating Officer and Senior Managing Director – CCHL
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Chan, Kai Kong
|
|
Singapore
|
|
Chief Financial Officer and Senior Managing Director – CCHL; Director – CITIC Capital Partners Limited, CCP IV GP Ltd. and 2019B Cayman Limited
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Zhang, Haitao
|
|
China
|
|
Director, Vice Chairman, President and Head of Asset Management – CCHL
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Al Kuwari, Abdulla Ali M A
|
|
Qatar
|
|
Director – CCHL; Principal – Qatar Investment Authority
|
|
Qatar Investment Authority
5th Floor, Q-Tel Tower,
Diplomatic St,
PO Box 23224, Doha, Qatar
|
|
|
|
|
|
|
|
Chen, I-hsuan
|
|
Taiwan
|
|
Director – CCHL; Senior Assistant Vice President – Fubon Life Insurance Co., Ltd.
|
|
Fubon Life Insurance Co., Ltd.
9F, No. 108, Section 1,
Dunhua South Road,
Taipei, 10557,
Taiwan, R.O.C.
|
DIRECTORS AND EXECUTIVE OFFICERS OF THE
REPORTING PERSONS
Name
|
|
Citizenship
|
|
Present Principal Occupation or Employment
|
|
Business Address
|
|
|
|
|
|
|
|
Mitchell, James Gordon
|
|
Britain
|
|
Director – CCHL; Chief Strategy Officer and Senior Executive Vice President – Tencent Holdings Limited
|
|
Tencent Holdings Limited
29F, Three Pacific Place,
Wanchai, Hong Kong
|
|
|
|
|
|
|
|
Lin, Yun-Ku
|
|
Taiwan
|
|
Director – CCHL; Senior Vice President – Fubon Life Insurance Co., Ltd.
|
|
Fubon Life Insurance Co., Ltd.
9F, No. 108, Section 1,
Dunhua South Road,
Taipei, 10557,
Taiwan, R.O.C.
|
|
|
|
|
|
|
|
Al-Sowaidi Mohammed, Saif SS
|
|
Qatar
|
|
Director – CCHL; Head (New York) – Qatar Investment Authority
|
|
Qatar Investment Authority
9 West 57th Street,
34th Floor, New York,
NY 10019, USA
|
|
|
|
|
|
|
|
Cheung, Miu
|
|
Australia
|
|
Senior Managing Director and Managing Partner of Structured Investment and Finance – CCHL
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Ching, Hiu Yuen
|
|
Hong Kong
|
|
Senior Managing Director and Managing Partner of Real Estate – CCHL
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Allegaert, Hans Omer
|
|
Belgium
|
|
Executive Director – CITIC Capital Partners Limited; Director – CCP IV GP Ltd. and 2019B Cayman Limited
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Xu, Zhichao
|
|
China
|
|
Vice Chairman, Head of Special Situations and President of CITIC Capital (Ningbo) Investment Management – CCHL
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Xin, Yuesheng
|
|
China
|
|
Senior Managing Director – CCHL; Managing Partner – CITIC Capital Partners Limited
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|
|
|
|
|
|
|
|
Zhan, Weibiao
|
|
China
|
|
Director – CCHL; Managing Director – Tencent Investment
|
|
28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
|